Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis

Nature Medicine

Volumn 7, Issue 7, 2001, Pages 827-832

  Bátkai, Sándor ^a   Járai, Zoltán ^a   Wagner, Jens A ^a   Goparaju, Sravan K ^a   Varga, Károly ^a   Liu, Jie ^a   Wang, Lei ^a   Mirshahi, Faridoddin ^b   Khanolkar, Atmaram D ^c   Makriyannis, Alexandros ^c   Urbaschek, Renata ^d   Garcia, Nelson ^b   Sanyal, Arun J ^b   Kunos, George ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID DERIVATIVE; RIMONABANT;

ANIMAL MODEL; ARTICLE; BILIARY CIRRHOSIS; CONTROLLED STUDY; HUMAN; HYPOTENSION; LIVER CIRRHOSIS; MESENTERY BLOOD FLOW; NONHUMAN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR DENSITY; VASODILATATION;

ANIMALS; ARACHIDONIC ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOCANNABINOIDS; ENDOTHELIUM, VASCULAR; HYPOTENSION; LIVER CIRRHOSIS; MALE; MASS SPECTROMETRY; MONOCYTES; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; VASODILATION;

EID: 0034928628     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/89953     Document Type: Article

References (43)

1. Relationship between splanchnic, peripheral and cardiac haemodynamics in liver cirrhosis of different degrees of severity
2. 4-treated cirrhotic rats
3. Hyperdynamic circulation of cirrhotic rats with ascites: Role of endotoxin, tumor necrosis factor-α and nitric oxide
4. Compensated cirrhosis: Natural history and prognostic factors
5. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility
6. Endotoxin levels measured by a chromatographic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis
7. Endotoxemia in patients with chronic liver diseases: Relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation
8. Prognostic value of plasma endotoxin levels in patients with cirrhosis
9. Hyperdynamic circulation in cirrhosis: A role for nitric oxide?
10. Enhanced nitric oxide synthase activity in portal hypertensive rabbits
11. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats
12. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis
13. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats
14. Smooth muscle-derived nitric oxide is elevated in isolated forearm veins in human alcoholic cirrhosis
15. Mesenteric vasodilator responses in cirrhotic rats: A role for nitric oxide?
16. Upregulation of endothelial constitutive NOS: A major role in the increased NO production in cirrhotic rats
17. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension
18. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
19. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide
20. Cannabinoid-induced hypotension and bradycardia in rats is mediated by CB1 cannabinoid receptors
21. Nitric oxide synthesis in mammals
22. Peripheral vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
23. Mechanism of sodium retention and ascites formation in cirrhosis
24. The systemic and portal hemodynamic effects of anandamide
25. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis
26. Increased portal venous resistance hinders portal pressure reduction during the administration of β-adrenergic blocking agents in a portal hypertensive model
27. Interaction of flow and resistance in maintenance of portal hypertension in a rat model
28. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
29. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
30. Dose-dependent effects of nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats
31. Production and physiological actions of anandamide in the vasculature of the rat kidney
32. Detection of an endogenous cannabinoid molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: Is 2-arachidonoylglycerol a possible vasomodulator?
33. Functional CB1 cannabinoid receptors in human vascular endothelial cells
34. Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues
35. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
36. The microcirculation during endotoxemia
37. 2+ channel current
38. High yield micronodular cirrhosis in the rat
39. Pentoxyfylline improves bacterial clearance during hemorrhage and endotoxemia
40. A simplified method for the isolation and culture of endothelial cells from pseudointima of transjugular intrahepatic portasystemic shunts
41. Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors